Cinfa MD Discusses Biosimilar Products Approaching The Market

At the 2017 BIO-Europe partnering meeting in Berlin, Germany, Ruediger Jankowsky managing director of Cinfa Biotech, talks about impending regulatory filings and decisions for its biosimilar drugs.

Video interview

During the recent BIO-Europe partnering conference, Mike Ward, global director of content for Informa Pharma Insights, chats to Ruediger Jankowsky, managing director of Cinfa Biotech, about the company's pipeline of biosimilar products for oncology and inflammatory diseases.

Cinfa Biotech has one product under regulatory review in Europe, a biosimilar version of Amgen Inc.’s Neulasta (pegfilgrastim), which...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from New Products

More from Scrip